We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Rachel Timberlake, Director of Business Development, Bend Bioscience. Contract manufacturing is a ~$275B global industry most people outside pharma have never heard of. Every drug you’ve ever taken and most of the medical devices you’ve ever used were made, at least in part, by a CDMO — a Contract Development and Manufacturing Organization — that your doctor, your pharmacist, and usually the drug company’s own marketing team will never mention. For the last decade, these businesses have been quietly rolled up by private equity, and 2026 is shaping up to be the year the ZIRP-era platforms either exit well, exit badly, or get absorbed into something bigger.
Timberlake has spent two decades inside this industry. She started at a small owner-operated CDMO doing — in her words — “chief cook and bottle washer” work and moved through roles of increasing scale into national sales leadership. Timberlake is one of the few people who can explain this industry in plain language — she has lived every altitude of it, from small-shop BD to national sales leadership inside a large platform, and she is now choosing what comes next.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- What is a CDMO? What does a sponsor actually buy, and why doesn’t every drug or device company just build its own factory?
- Chief cook and bottle washer to national sales — what did a small CDMO look like when you started, and what did business development actually mean back then?
- When a biotech CEO calls a CDMO for the first time, what does the first ninety days actually look like — and where does it most often go sideways?
- Onshoring is the tailwind everyone is talking about — BIOSECURE, tariffs, GLP-1 capacity. What are you actually seeing in the RFPs?
- What should a founder ask a CDMO in diligence that most of them don’t think to ask?
- What is the biggest anti-pattern you see at the sponsor–CDMO interface?
- What’s the kind of problem you’d most want to work on next?
Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.
Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
No comments:
Post a Comment